Prospective assessment of breakthrough infections and neurotoxicity and their association with cefepime trough concentrations in patients with febrile neutropenia-Reference-Cited by-同舟云学术

Prospective assessment of breakthrough infections and neurotoxicity and their association with cefepime trough concentrations in patients with febrile neutropenia

Published:2022-01 Issue:1 Volume:59 Page:106472
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Gijsen Matthias^ORCID,Bekkers Britt,Maertens Johan,Lagrou Katrien,Desmet Stefanie,Dreesen Erwin^ORCID,Peetermans Willy E.,Debaveye Yves,Spriet Isabel^ORCID

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference28 articles.

1. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America;Freifeld;Clin Infect Dis,2011

2. Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO);Heinz;Ann Hematol,2017

3. Management of febrile neutropaenia: ESMO clinical practice guidelines;Klastersky;Ann Oncol,2016

4. A model-based analysis of the predictive performance of different renal function markers for cefepime clearance in the ICU;Jonckheere;J Antimicrob Chemother,2016

5. Adequacy of high-dose cefepime regimen in febrile neutropenic patients with hematological malignancies;Sime;Antimicrob Agents Chemother,2015

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cefepime trough levels and clinical outcomes in patients undergoing universal therapeutic drug monitoring: A prospective cohort study;CMI Communications;2024-12

2. The eGFR parameter model helps predict blood drug concentration of amisulpride in patients with schizophrenia;2024-08-09

3. Model-informed precision dosing: State of the art and future perspectives;Advanced Drug Delivery Reviews;2024-08

4. Cefepime-induced neurotoxicity in non-critically ill medical patients: a retrospective cohort study;Signa Vitae;2024

5. The Trend of Cefepime-Induced Neurotoxicity: A Systematic Review;Cureus;2023-06-26